News Room

11 - 20 of 1512

AML Immunotherapy Trial Opens

Published on in Oncology Update

CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.

News Archive Search

Can't find what you are looking for? Search the news archives.